Topiramate
Brand name: Topiramate
Rank #283 of 500 drugs by total cost
$41.9M
Total Cost
1,141,093
Total Claims
$41.9M
Total Cost
33,982
Prescribers
$37
Cost per Claim
130,668
Beneficiaries
1,895,310
30-Day Fills
$1,233
Avg Cost/Provider
34
Avg Claims/Provider
About Topiramate
Topiramate (sold as Topiramate) was prescribed 1,141,093 times by 33,982 Medicare Part D providers in 2023, costing the program $41.9M. At $37 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 280 | Efgartigimod Alfa-Fcab (Vyvgart) | $42.6M | 1,005 |
| 281 | Hydrochlorothiazide (Hydrochlorothiazide) | $42.4M | 7,879,021 |
| 282 | Tadalafil (Tadalafil) | $42.3M | 91,082 |
| 283 | Topiramate (Topiramate) | $41.9M | 1,141,093 |
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology